These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24997180)

  • 41. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL; Yu F
    Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of availability of anti-vascular endothelial growth factor therapy on visual impairment and blindness due to neovascular age-related macular degeneration.
    Campbell JP; Bressler SB; Bressler NM
    Arch Ophthalmol; 2012 Jun; 130(6):794-5. PubMed ID: 22801846
    [No Abstract]   [Full Text] [Related]  

  • 43. Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact.
    Shienbaum G; Gupta OP; Fecarotta C; Patel AH; Kaiser RS; Regillo CD
    Am J Ophthalmol; 2012 Mar; 153(3):468-473.e1. PubMed ID: 21996309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
    Shin JY; Kwon KY; Byeon SH
    Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.
    Miskala PH; Hawkins BS; Mangione CM; Bass EB; Bressler NM; Dong LM; Marsh MJ; McCaffrey LD;
    Arch Ophthalmol; 2003 Apr; 121(4):531-9. PubMed ID: 12695250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. One-year results of treatment with bevacizumab alone or ranibizumab alone for low visual acuity due to neovascular age-related macular degeneration.
    Ozkaya A; Alkin Z; Agca A; Satici T; Karakucuk Y; Yazici AT; Demirok A
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):865-9. PubMed ID: 24053539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration.
    Switzer DW; Mendonça LS; Saito M; Zweifel SA; Spaide RF
    Retina; 2012 Jul; 32(7):1265-71. PubMed ID: 22222760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EFFECT OF SYSTEMIC BETA-BLOCKERS, ACE INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS ON DEVELOPMENT OF CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION.
    Thomas AS; Redd T; Hwang T
    Retina; 2015 Oct; 35(10):1964-8. PubMed ID: 25996426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors influencing poor visual outcome in patients treated with photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration.
    Manku KK; Rotchford A; Whitaker J; Amoaku WM
    Clin Exp Ophthalmol; 2007; 35(4):330-4. PubMed ID: 17539784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical characteristics of reticular pseudodrusen in the fellow eye of patients with unilateral neovascular age-related macular degeneration.
    Hogg RE; Silva R; Staurenghi G; Murphy G; Santos AR; Rosina C; Chakravarthy U
    Ophthalmology; 2014 Sep; 121(9):1748-55. PubMed ID: 24856310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Xu L; Mrejen S; Jung JJ; Gallego-Pinazo R; Thompson D; Marsiglia M; Freund KB
    Retina; 2015 Feb; 35(2):176-86. PubMed ID: 25387047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inequalities in Uptake and Use of Digital Applications for Home-Monitoring of Neovascular Age-Related Macular Degeneration in an Elderly Visually Impaired Population: The MONARCH Study.
    Hogg RE; Wickens R; O'Connor S; Gidman E; Ward E; Peto T; Burton BJL; Knox P; Lotery AJ; Sivaprasad S; Donnelly M; Rogers CA; Reeves BC
    Transl Vis Sci Technol; 2024 Mar; 13(3):2. PubMed ID: 38427348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Social deprivation and health. Disease registers valuable if geographically defined.
    Killalea D; Davis A; Hanstock G; Hanson J
    BMJ; 1993 Dec; 307(6917):1499. PubMed ID: 8281117
    [No Abstract]   [Full Text] [Related]  

  • 55. Helping patients who go it alone.
    Trueland J
    Nurs Stand; 2015 Feb; 29(25):22-3. PubMed ID: 25690209
    [No Abstract]   [Full Text] [Related]  

  • 56. GEOGRAPHIC ATROPHY INCIDENCE AND PROGRESSION AFTER INTRAVITREAL INJECTIONS OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS FOR AGE-RELATED MACULAR DEGENERATION: A Meta-Analysis.
    Eshtiaghi A; Issa M; Popovic MM; Muni RH; Kertes PJ
    Retina; 2021 Dec; 41(12):2424-2435. PubMed ID: 34101693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do Socioeconomic Inequalities Exist Within Ophthalmology and Orthoptics in the UK?: A Scoping Review.
    England L; O'Connor A
    Br Ir Orthopt J; 2024; 20(1):31-47. PubMed ID: 38250169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of the first United Kingdom COVID-19 lockdown on environmental air pollution, digital display device use and ocular surface disease symptomatology amongst shielding patients.
    Recchioni A; Makanvand M; Poonit N; Wallace GR; Bartington S; Bloss W; Rauz S
    Sci Rep; 2022 Dec; 12(1):20820. PubMed ID: 36460705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Socioeconomic deprivation and development of diabetic retinopathy in patients with type 1 diabetes mellitus.
    Alvarez-Ramos P; Jimenez-Carmona S; Alemany-Marquez P; Cordoba-Doña JA; Aguilar-Diosdado M
    BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33177040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative Analysis of OCT for Neovascular Age-Related Macular Degeneration Using Deep Learning.
    Moraes G; Fu DJ; Wilson M; Khalid H; Wagner SK; Korot E; Ferraz D; Faes L; Kelly CJ; Spitz T; Patel PJ; Balaskas K; Keenan TDL; Keane PA; Chopra R
    Ophthalmology; 2021 May; 128(5):693-705. PubMed ID: 32980396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.